China · Delayed Price · Currency is CNY Mingchen Health Statistics
Total Valuation
Mingchen Health has a market cap or net worth of CNY 4.45 billion. The enterprise value is 4.20 billion.
| Market Cap | 4.45B |
| Enterprise Value | 4.20B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jun 9, 2026 |
Share Statistics
Mingchen Health has 264.28 million shares outstanding. The number of shares has increased by 0.20% in one year.
| Current Share Class | 264.28M |
| Shares Outstanding | 264.28M |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 41.03% |
| Owned by Institutions (%) | 3.43% |
| Float | 155.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.62 |
| PB Ratio | 5.66 |
| P/TBV Ratio | 10.24 |
| P/FCF Ratio | 69.32 |
| P/OCF Ratio | 35.56 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 65.47 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.71 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.20 |
| Interest Coverage | -21.55 |
Financial Efficiency
Return on equity (ROE) is -2.57% and return on invested capital (ROIC) is 32.12%.
| Return on Equity (ROE) | -2.57% |
| Return on Assets (ROA) | -3.41% |
| Return on Invested Capital (ROIC) | 32.12% |
| Return on Capital Employed (ROCE) | -7.89% |
| Weighted Average Cost of Capital (WACC) | 7.19% |
| Revenue Per Employee | 1.30M |
| Profits Per Employee | -13,657 |
| Employee Count | 1,305 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 10.24 |
Taxes
In the past 12 months, Mingchen Health has paid 28.30 million in taxes.
| Income Tax | 28.30M |
| Effective Tax Rate | 376.02% |
Stock Price Statistics
The stock price has increased by +10.14% in the last 52 weeks. The beta is 0.59, so Mingchen Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +10.14% |
| 50-Day Moving Average | 17.54 |
| 200-Day Moving Average | 21.41 |
| Relative Strength Index (RSI) | 41.01 |
| Average Volume (20 Days) | 3,326,127 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mingchen Health had revenue of CNY 1.70 billion and -17.82 million in losses. Loss per share was -0.07.
| Revenue | 1.70B |
| Gross Profit | 941.37M |
| Operating Income | -65.01M |
| Pretax Income | 7.53M |
| Net Income | -17.82M |
| EBITDA | -47.66M |
| EBIT | -65.01M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 321.68 million in cash and 77.26 million in debt, with a net cash position of 244.42 million or 0.92 per share.
| Cash & Cash Equivalents | 321.68M |
| Total Debt | 77.26M |
| Net Cash | 244.42M |
| Net Cash Per Share | 0.92 |
| Equity (Book Value) | 786.10M |
| Book Value Per Share | 2.99 |
| Working Capital | 285.30M |
Cash Flow
In the last 12 months, operating cash flow was 125.08 million and capital expenditures -60.92 million, giving a free cash flow of 64.16 million.
| Operating Cash Flow | 125.08M |
| Capital Expenditures | -60.92M |
| Depreciation & Amortization | 17.35M |
| Net Borrowing | 6.33M |
| Free Cash Flow | 64.16M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 55.42%, with operating and profit margins of -3.83% and -1.05%.
| Gross Margin | 55.42% |
| Operating Margin | -3.83% |
| Pretax Margin | 0.44% |
| Profit Margin | -1.05% |
| EBITDA Margin | -2.81% |
| EBIT Margin | -3.83% |
| FCF Margin | 3.78% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.29%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 0.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.20% |
| Shareholder Yield | 0.09% |
| Earnings Yield | -0.40% |
| FCF Yield | 1.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 31, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | May 31, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Mingchen Health has an Altman Z-Score of 9.29 and a Piotroski F-Score of 4.
| Altman Z-Score | 9.29 |
| Piotroski F-Score | 4 |